Vital Capital
Vital Capital Fund, established in 2010 and headquartered in Switzerland, is a private equity fund with a focus on investing in Sub-Saharan Africa. With a capital base of $350 million, the fund aims to enhance community quality of life while delivering substantial financial returns to its investors. The firm’s seasoned team possesses over 30 years of on-the-ground experience across various industries in Africa, having successfully managed billions of dollars in large-scale infrastructure projects. Vital Capital primarily targets infrastructure development, while also emphasizing urban housing, agro-industrial solutions, education, and healthcare. By aligning investment opportunities with the pressing needs of communities, the fund seeks to create a significant impact, improving living standards alongside financial performance.
Established for over 35 years in the United Kingdom, Sollatek is a manufacturer and world leader in voltage protection, power control, energy saving, temperature control and solar energy.
TOMA Biosciences, Inc. develops reagent kits that enable laboratories and researchers to uncover genomic changes in tumors. The company offers TOMA OS-Seq, an oncology-focused gene analysis solution. It serves laboratories, hospital systems, and research institutions worldwide. The company was incorporated in 2011 and is based in Foster City, California.
Social Finance Israel (SFI) is an Israeli not-for-profit organization, established in 2013, in order to issue Social Impact Bonds in Israel. Social Impact Bonds are an innovative way of attracting new investment from private investors in order to fund social organizations with a proven track record that aim to tackle Israel's most pressing social issues. Financial returns to investors are made by the public sector on the basis of improved social outcomes. Social Finance Israel (SFI) is based in Tel Aviv, Israel, and is a sister organization of Social Finance UK and Social Finance US.